Abstract:Ulcerative colitis (UC) is an idiopathic inflammatory disease mainly affects the large bowel and the rectum. The pathogenesis of this disease has not been fully elucidated, while the disruption of the intestinal barrier function triggered by various stimulating factors related to the host genetics, immunity, gut microbiota, and environment has been considered to be major mechanisms that affect the development of UC. Given the limited effective therapies, the treatment of this disease is not ideal and its incidence and prevalence are increasing. Therefore, developing new therapies with high efficiency and efficacy is important for treating UC. Many recent studies disclosed that numerous herbal decoctions and natural compounds derived from traditional herbal medicine showed promising therapeutic activities in animal models of colitis and have gained increasing attention from scientists in the study of UC. Some of these decoctions and compounds can effectively alleviate colonic inflammation and relieve clinical symptoms in animal models of colitis via regulating intestinal barrier function. While no study is available to review the underlying mechanisms of these potential therapies in regulating the integrity and function of the intestinal barrier. This review aims to summarize the effects of various herbal decoctions or bioactive compounds on the severity of colonic inflammation via various mechanisms, mainly including regulating the production of tight junction proteins, mucins, the composition of gut microbiota and microbial-associated metabolites, the infiltration of inflammatory cells and mediators, and the oxidative stress in the gut. On this basis, we discussed the related regulators and the affected signaling pathways of the mentioned traditional medicine in modulating the disruption or restoration of the intestinal barrier, such as NF-κB/MAPK, PI3K, and HIF-1α signaling pathways. In addition, the possible limitations of current studies and a prospect for future investigation and development of new UC therapies are provided based on our knowledge and current understanding. This review may improve our understanding of the current progression in studies of traditional medicine-derived therapies in protecting the intestinal barrier function and their roles in alleviating animal models of UC. It may be beneficial to the work of researchers in both basic and translational studies of UC.

Intervention and potential mechanism of non-starch polysaccharides from natural resources on ulcerative colitis: A review

The Potential Role of Plant Polysaccharides in Treatment of Ulcerative Colitis

The Function of Natural Polysaccharides in the Treatment of Ulcerative Colitis

The latest progress of natural food polysaccharides preventing ulcerative colitis by regulating intestinal microbiota

Current advances in the anti-inflammatory effects and mechanisms of natural polysaccharides

Influence of Natural Polysaccharides on Intestinal Microbiota in Inflammatory Bowel Diseases: An Overview

Natural Food Polysaccharides Ameliorate Inflammatory Bowel Disease and Its Mechanisms

Glycosides as Potential Medicinal Components for Ulcerative Colitis: A Review

Potential of natural flavonols and flavanones in the treatment of ulcerative colitis

Research progress in the treatment of inflammatory bowel disease with natural polysaccharides and related structure–activity relationships

Regulation of the intestinal flora using polysaccharides from Callicarpa nudiflora Hook to alleviate ulcerative colitis and the molecular mechanisms involved

Harnessing nature's pharmacy: investigating natural compounds as novel therapeutics for ulcerative colitis

Research progress of natural plant polysaccharides inhibiting inflammatory signaling pathways and regulating intestinal flora and metabolism to protect inflammatory bowel disease

Potential of plant-based polysaccharides as therapeutic agents in ulcerogenic diseases of the gastrointestinal tract: A review

Effects of Pine Pollen Polysaccharides and Sulfated Polysaccharides on Ulcerative Colitis and Gut Flora in Mice

Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy

Network pharmacology based research into the effect and potential mechanism of Portulaca oleracea L . polysaccharide against ulcerative colitis

Potent Intestinal Mucosal Barrier Enhancement of Nostoc commune Vaucher Polysaccharide Supplementation Ameliorates Acute Ulcerative Colitis in Mice Mediated by Gut Microbiota

Application of Polymers as Drug Nanocarriers in the Oral Treatment of Ulcerative Colitis

The mechanism of traditional medicine in alleviating ulcerative colitis: regulating intestinal barrier function

Xylan acetate ester ameliorates ulcerative colitis through intestinal barrier repair and inflammation inhibition via regulation of macrophage M1 polarization